Investing

Top Analyst Upgrades and Downgrades: Altbaba, AutoDesk, AutoZone, CBS, Eli Lilly, Lululemon, Michael's, Target and More

Mueller Water Products Inc. (NYSE: MWA) saw its target price lowered to $12.50 from $14 at Oppenheimer, but the firm kept an Overweight rating on the stock. That price target compares with the consensus figure of $13.45. The stock ended trading Wednesday at $8.97.

Target Corp. (NYSE: TGT) was downgraded to Hold from Buy at Morningstar Research. The 52-week trading range for the big-box store operator is $60.15 to $90.39, and the posted consensus price objective is $84.01. The shares ended trading on Wednesday at $65.11, up almost 6% on the day.

Other key analysts upgrades and downgrades were seen in the following:

Ashland Global Holdings Inc. (NYSE: ASH) was raised to Overweight from Neutral at JPMorgan. The 52-week trading range for the stock is $64.81 to $86.63, and the consensus price target is $94.80. The shares closed Wednesday at $68.22, up almost 5% on the day.

KBR Inc. (NYSE: KBR) was named the top 2019 pick at MKM Partners, which has set a $25 price target. The consensus target is $23.25, and the stock closed trading on Wednesday at $15, up over 7%.

MongoDB Inc. (NASDAQ: MDB) saw its price target raised to $79 from $72 at Morgan Stanley, which also raised 2019 estimates. The consensus price target is higher at $92.31. Shares ended Wednesday at $79.69, up over 11%.

Pattern Energy Group Inc. (NASDAQ: PEGI) was raised to Neutral from Hold at Merrill Lynch. Over the past year, the stock has traded between $16.58 and $21.97. The consensus price target is set at $23.15, and the stock closed Wednesday at $18.66, up 6.5%.

Taiwan Liposome Co. Ltd. (NASDAQ: TLC) was started with an Overweight rating and an $11 price target at Cantor Fitzgerald. The consensus target is $11. The analyst noted that the company’s expertise and experience with liposome science have yielded the BioSeizer and NanoX formulation technologies that, in its view, have the potential to improve the pharmacologic and therapeutic potential of approved pharmacophores to treat various medical disorders. The stock closed Wednesday at $5.14, down over 10%.

Michaels Companies Inc. (NASDAQ: MIK) saw its target price slashed from $18 to $14 at Loop Capital. That compares with a consensus target of $20.91. The shares closed Wednesday at $13.58.

In case you missed it because of the holidays, here are last Friday’s top analyst upgrades and downgrades. They included Apple, Applied Materials, Biogen, Cyberark, Electronic Arts, Marathon, Nike, NXP Semiconductors and many more.